Polyunsaturated fatty acids and inflammatory diseases

Biomedicine and Pharmacotherapy

Volumn 56, Issue 8, 2002, Pages 388-396

  Gil, A ^a  

^a Facultad de Farmacia   (Spain)

Author keywords

Inflammatory disease; N 3 Fatty acids; Polyunsaturated fatty acids

Indexed keywords

ALLERGEN; ARACHIDONIC ACID; BIOGENIC AMINE; CYTOKINE; FISH OIL; GAMMA LINOLENIC ACID; ICOSANOID; ICOSAPENTAENOIC ACID; OMEGA 3 FATTY ACID; POLYUNSATURATED FATTY ACID; TOXIN; TRINITROBENZENESULFONIC ACID; VEGETABLE OIL; AUTACOID; OMEGA 6 FATTY ACID; UNSATURATED FATTY ACID;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; ATHEROSCLEROSIS; CELL DEATH; CELL TYPE; CHRONIC HEPATITIS; CHRONIC INFLAMMATION; CLINICAL TRIAL; CYTOKINE PRODUCTION; DIET SUPPLEMENTATION; ECZEMA; ENTERITIS; GASTROINTESTINAL MUCOSA; HISTOPATHOLOGY; HUMAN; HYPERSENSITIVITY REACTION; INFLAMMATORY DISEASE; LIVER CIRRHOSIS; LUNG FIBROSIS; MEDIATOR RELEASE; MICROORGANISM; MUCOSA INFLAMMATION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PSORIASIS; RHEUMATOID ARTHRITIS; TISSUE NECROSIS; ULCERATIVE COLITIS; DIET THERAPY; DRUG EFFECT; IMMUNE SYSTEM; INFLAMMATION; METABOLISM; REVIEW;

FATTY ACIDS, OMEGA-3; FATTY ACIDS, OMEGA-6; FATTY ACIDS, UNSATURATED; HUMANS; IMMUNE SYSTEM; INFLAMMATION; INFLAMMATION MEDIATORS;

EID: 0036774174     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0753-3322(02)00256-1     Document Type: Article

References (51)

1. Almallah Y.Z., El Tahir A., Heys S.D., Richardson S., Eremin O. Distal proctocolitis and n-3 polyunsaturated fatty acids: the mechanism(s) of natural cytotoxicity inhibition. Eur J Clin Invest. 30:2000;58-65.
2. Almallah Y.Z., Ewn S.W., El Tahir A., Mowat N.A., Brunt P.W., Sinclair T.S., Heys S.D., Eremin O. Distal proctocolitis and n-3 polyunsaturated fatty acids: the mucosal effects in situ. J Clin Immunol. 20:2000;68-76.
3. Alsan A., Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcerative colitis: a double blind, placebo controlled, crossover study. Am J Gastroenterol. 87:1992;432-437.
4. Belluzi A., Boschi S., Brignola C., Munarini A., Cariani G., Miglio F. Polyunsaturated fatty acids and inflammatory bowel disease. Am J Clin Nutr. 71:(Suppl 1):2000;339S-342S.
5. Belluzi A., Brignola C., Campieri M., Pera A., Boschi S., Migliolo M. Effect of and enteric coated fish oil preparation on relapses in Crohn's disease. N Engl J M. 334:1996;1557-1560.
6. Bernstein C.N., Pettigrew N.M., El-Gabalawy H.S., Sargent M., Meu Y., Wilkins J. The differential expression of a novel intestinal epithelial glycoprotein in various forms of inflammatory bowel disease. Am J Clin Pathol. 106:1996;42-51.
7. Bittinger S.B., Cartwright I., Tucker W.F.G., et al. A double-blind, randomized placebo-controlled trial of fish oil in psoriasis. Lancet. 1:1988;378-380.
8. Bjoerneboe A., Soyland E., Bjoerneboe G.E., Rajka G., Drevon C.A. Effect of dietary supplementation with eicosapentaenoic acid in the treatment of atopic dermatitis. Br J Dermatol. 117:1987;463-469.
9. Blok W.L., Katan M.B., Van der Meer J.W.M. Modulation of inflammation and cytokine production by dietary (n-3) fatty acids. J Nutr. 126:1996;1515-1533.
10. Burke A., Lichtenstein G.R., Rombeau J.L. Nutrition and ulcerative colitis. Baillieres Clin. Gastroenterol. 11:1997;153-174.
11. Calder P.C. Polyunsaturated fatty acids, inflammation and immunity. Lipids. 36:2001;1007-1024.
12. Calder P.C., Yakoob P., Thies F., Wallace F.A., Miles E.A. Fatty acids and lymphocyte functions. Br J Nutr. 87:(Suppl 1):2002;S31-S48.
13. Cotran R.S., Kumar V., Robbins S. Inflammation and repair. In: Schoen FJ, editor. Pathologic basis of disease. 5th ed. New York: W. B Saunders Company; 1995. p. 57-104.
14. De Pablo M.A., Gaforio J.J., Puertollano M.A., Ortega E., Álvarez de Cienfuegos G. Modulación de las funciones inmunes por ácidos grasos. Papel del aceite de oliva en la inmunidad. 2000;Universidad Internacional de Baeza, Jaén.
15. Dichi I., Frenhane P., Dichi J.B., Correa C.R., Angeleli A.Y., Bicudo M.H., Rodrigues M.A., Victoria C.R., Burini R.C. Comparison of omeg-3 fatty acids and sulfasalazine in ulcerative colitis. Nutrition. 16:2000;87-90.
16. Esteve M., Navarro E., Klaasen J., Abad-Lacruz A., González-Huix F., Cabré E., Ramos E., Condom E., Fernández-Bañares F., Pastor C., Humbert P., Marti-Rague J., Gassull M.A. Plasma and mucosal fatty acid pattern in colectomized ulcerative colitis patients. Dig Dis Sci. 43:1998;1071-1078.
17. Esteve-Comas M., Núñez M.C., Fernández-Bañares F., Abad-Lacruz A., Cabré E., González-Huix F., Bertrán X., Gassull M.A. Abnormal plasma polyunsaturated fatty acid pattern in non-active inflammatory bowel disease. Gut. 34:1993;1370-1373.
18. Esteve-Comas M., Ramírez M., Boix J., Fernández-Bañares F., González-Huix F., Abad A., Gil A., Cabré E., Quer J.C., Llovet J., Gassull M.A. The influence of activity of the disease in polyunsaturated fatty acid (PUFA) pattern in inflammatory bowel disease. Clin Nutr. 9:(Suppl):1990;62-69.
19. Fiocchi A., Sala M., Signoroni P., Banderali G., Agostoni C., Riva E. The efficacy and safety of gamma-linolenic acid en the treatment of infantile atopic dermatitis. J Int Med Res. 22:1994;24-32.
20. Galli E., Picardo M., Chini L., et al. Analysis of polyunsaturated fatty acids in newborn sera: a screening tool for atopic disease? Br J Dermatol. 130:1994;752-756.
21. Gassull M. New insights in nutritional therapy in inflammatory disease. Clin Nutr. 20:(Suppl 1):2001;113-121.
22. Griffiths A.M. Inflammatory bowel disease. Nutrition. 14:1998;778-791.
23. Grimble R.F., Tappia P.S. Modulation of pro-inflammatory cytokine biology by unsaturated fatty acids. Z Ernahrungswiss. 37:1998;57-65.
24. Hawthorne A.B., Daneshmend T.K., Hawkey C.J., et al. Treatment of ulcerative colitis with fish oil supplementation: a prospective 12 month randomised controlled trial. Gut. 33:1992;922-928.
25. Horrobin D.F., Morse F.F. Evening primrose oil and atopic eczema. Lancet. 345:1995;260-261.
26. Horrobin D.F. Essential fatty acid metabolism and its modification in atopic eczema. Am J clin Nutr. 71:(Suppl):2000;367S-372S.
27. James M.J., Gibson R.A., Cleland L.G. Dietary polyunsaturated fatty acids and inflammatory mediator production. Am J Clin Nutr. 71:(Suppl):2000;343S-348S.
28. Kremer J.M. N-3 fatty acid supplements in rheumatoid arthritis. Am J Clin Nutr. 71:(Suppl):2000;349S-351S.
29. Lassus A., Dahlgren A.L., Halpern M.J., et al. Effects of dietary supplementation with ethyl ester lipids (angiosan) in patients with psoriasis and psoriatic arthritis. J Int Med Res. 18:1990;68-73.
30. Lee T.H., Hoover R.L., Williams J.D., Sperling R.I., Ravalese I.J., Spur B.W. Effect of dietary enrichment with eicosapentaenoic and docosahexaenoic acids on in vitro neutrophil and monocyte leukotriene generation and neutrophil function. N Eng J M. 312:1985;1217-1224.
31. Loeschke K., Ueberschaer B., Pietsch A., et al. n-3 Fatty acids retard early relapse in ulcerative colitis in remission. Dig Dis Sci. 41:1996;2087-2094.
32. Lorenz R., Weber P.C., Szimnau P., Heldwein W., Stasser T., Loeschke K. Supplementation with n-3 fatty acids from fish oil in chronic inflammatory bowel disease: a randomized placebo-controlled, double blind cross-over trial. J Intern M. 225:(Suppl):1989;225-232.
33. Lorenz-Meyer H., Bauer P., Nicolay C., et al. Omega-3 fatty acids and carbohydrates diet for maintenance of remission in Crohn's disease. Scan J Gastroenterol. 31:1996;778-785.
34. Maté J., Castaños J., García-Samaniego J., Pajares J.M. Does dietary fish oil maintain the remission of Crohn's disease (CD): a study case control. Gastroenterology. 100:1993;A-228. (abstract).
35. McCall T.B., O'Leary D., Bloomfield J., et al. Therapeutic potential of fish oil in the treatment of ulcerative colitis. Aliment Pharmacol Ther. 3:1989;415-424.
36. Miller C.C., Tang W., Ziboh V.A., Fletcher M.P. Dietary supplementation with ethyl ester concentrates of fish oil (n-3) and borage oil (n-6) polyunsaturated fatty acids induces epidermal generation of local putative anti-inflammatory metabolites. J Invest Dermatol. 96:1991;98-103.
37. Nagakura T., Matsuda S., Shichijyo K., Sugimoto H., Hata K. Dietary supplementation with fish oil rich in omega-3 polyunsaturated fatty acids in children with bronchial asthma. Eur Respir J. 16:2000;861-865.
38. Nieto N., Fernández M.I., Torres M.I., Ríos A., Suárez M.D., Gil A. Dietary (n-3) and (n-6) long-chain polyunsaturated fatty acids affect cellular antioxidant defense system in rats with experimental ulcerative colitis induced by trinitrobenzene sulfonic acid. Dig Dis Sci. 43:1998;2676-2687.
39. Nieto N., Girón M.D., Suárez M.D., Gil A. Changes in plasma and colonic mucosa fatty acids profiles in rats with ulcerative colitis induced by trinitrobenzenesulfonic acid. Dig Dis Sci. 43:1998;2688-2695.
40. Nieto N., Torres M.I., Ríos A., Gil A. Dietary polyunsaturated fatty acids improve histological and biochemical alterations in experimental ulcerative colitis. J Nutr. 132:2002;11-19.
41. Pacheco S., Hillier K., Smith C. Increased arachidonic acid levels in phospholipids of human colonic mucosa in inflammatory bowel disease. Clin Sci. 73:1987;361-364.
42. Salomón P., Asher A., Kornbluth, Janowitz H.D. Treatment of ulcerative colitis with fish oil n-3 fatty acid: an open trial. J Clin Gastroenterol. 12:1990;157-161.
43. Schwartz J. Role of polyunsaturated fatty acids in lung disease. Am J Clin Nutr. 7:(Suppl):2000;393S-396S.
44. Shoda R., Matsueda K., Yamato S., Umeda N. Epidemiologic analysis of Crohn's disease in Japan: increased dietary intake of (n-6) polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn's disease in Japan. Am J Clin Nutr. 63:1996;741-745.
45. Soyland E., Funk K., Rajka G., et al. Dietary supplementation with very long-chain n-3 fatty acids in patients with atopic dermatitis. A double-blind, multicentre study. Br J Dermatol. 130:1994;757-764.
46. Stenson W.F., Cort D., Rodgers J., et al. Dietary supplementation with fish oil in ulcerative colitis. Ann Intern M. 116:1992;609-614.
47. Ternowitz T., Fogh K. Kragballe K. 15-hydroxyeicosatetranoic acid (15-HETE) specifically inhibits LTB4-induced chemotaxis of human neutrophils. Skin Pharmacol. 1:1988;93-99.
48. Wright S. Essential fatty acids and the skin. Br J Dermatol. 125:1991;503-515.
49. Young R.J., Vanderhoof J.A. Nutrition in pediatric inflammatory bowel disease. Nutrition. 16:2000;78-80.
50. Ziboh V.A., Miller C.C., Cho Y. Metabolism of polyunsaturated fatty acids by skin epidermal enzymes: generation of antiinflammatory and antiproliferative metabolites. Am J Clin Nutr. 71:(Suppl):2000;361S-366S.
51. Ziboh V.A. The significance of polyunsaturated fatty acids in cutaneous biology. Lipids. 31:1996;249-253.